Top 5 Holdings

Top 5 Holdings

As of February 28, 2018

Position Company % Estimated Net Assets*
1. Pivotal Systems, Inc. 20.5%
2. QMAT, Inc. 14.3%
3. IntraOp Medical Corp. 12.4%
4. Nutanix, Inc. 9.0%
5. Revasum, Inc. 8.8%

Additional Information

On November 13, 2017, the Fund announced a plan to repurchase up to $2 million worth of SVVC stock in the open market by March 30, 2018. Through the end of February 2018, we had repurchased and retired 128,551 shares of stock at a total cost of approximately $1.1 million. As of February 28, 2018, the Fund had 7,302,146 shares outstanding.

The Fund also announced that as of February 28, 2018, estimated net assets of the Fund were approximately $169 million, or $23.13 per share, including cash and cash equivalents of approximately $0.24 per share. As of that date, the Fund's top five holdings constituted 65.0% of the Fund's estimated net assets.* Complete financial statements and a detailed schedule of investments as of December 31, 2017, will be available with the Fund's annual report filing on Form 10-K in March 2018.

*Estimated net assets as of February 28, 2017, represent net assets of approximately $174 million as of December 31, 2017, plus the net change in unrealized appreciation/depreciation and realized gains/losses on publicly traded and private securities since December 31, 2017. For the purposes of calculating the percentage of net assets represented by each investment, the value of each holding is determined by the most recent of: (1) the purchase price, (2) the market value for public securities, less any discounts taken due to restrictions on the stock, or (3) the December 31, 2017, fair value of each security, as determined under procedures approved by our Board of Directors.